Join BJS Academy
BJS Academy>Randomized clinical ...>Effect of the use of...
Normal View Dyslexic View

Effect of the use of reinforced stapling on the occurrence of pancreatic fistula after distal pancreatectomy. Results of the REPLAY (REinforcement of the Pancreas in distaL pAncreatectomY) multicenter randomized clinical trial.

27 December 2022
Randomized clinical trials HPB
Merdrignac A, Garnier J, Dokmak S, Regenet N, Lesurtel M, Mabrut JY, et al.

Ann Surg 2022; 276: 769-775.

Use of the reinforced stapler actually increased the overall rate of pancreatic fistula compared to the standard device: 83 versus 67.7 per cent (P=0.021), in this study that included 199 procedures. The rates of clinically relevant fistula and other complications was similar.

Comment: Disappointing results.

BJS Foundation Limited
BJS Academy
0000-0000
BJS Foundation Limited
London, UK
rct154
Randomized clinical trials
Randomized clinical trials
HPB
Effect of the use of reinforced stapling on the occurrence of pancreatic fistula after distal pancreatectomy. Results of the REPLAY (REinforcement of the Pancreas in distaL pAncreatectomY) multicenter randomized clinical trial.
Merdrignac A, Garnier J, Dokmak S, Regenet N, Lesurtel M, Mabrut JY, et al.
27122022
Ann Surg 2022; 276: 769-775.
Use of the reinforced stapler actually increased the overall rate of pancreatic fistula compared to the standard device: 83 versus 67.7 per cent (P=0.021), in this study that included 199 procedures. The rates of clinically relevant fistula and other complications was similar.
Comment: Disappointing results.
Published on: 27 December 2022
Article ID: rct154

Related articles

Temporary portocaval shunt provides superior intraoperative hemodynamics and reduces blood loss and duration of surgery in live donor liver transplantation. A randomized controlled trial.

Kumar M, Patil NS, Mohapatra N, Sindwani G, Dhingra U, Yadav A et al.
Ann Surg 2024; 279: 932-944.

16 August 2024

Upfront endoscopic necrosectomy or step-up endoscopic approach for infected necrotising pancreatitis (DESTIN): a single-blinded, multicentre, randomised trial.

Bang JY, Lakhtakia S, Thakkar S, Buxbaum JL, Waxman I, Sutton B et al, on behalf of the United States Pancreatic Disease Study Group.

16 August 2024

Neoadjuvant FOLFIRINOX versus upfront surgery for resectable pancreatic head cancer (NORPACT-1): a multicentre, randomised, phase 2 trial.

Labori KJ, Bratlie SO, Andersson B, Angelsen J-H, Biorserud C, Bjornsson B et al, for the Nordic Pancreatic Cancer Trial-1 study group.

30 August 2024
Home
  • Normal view
  • Dyslexic view
Info
Copied!